EVOLENT HEALTH INC - A (EVH)

US30050B1017 - Common Stock

11.32  -0.09 (-0.79%)

After market: 11.0828 -0.24 (-2.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
908M
-1.80%
1.352B
48.90%
1.964B
45.26%
2.586B
31.68%
2.957B
14.35%
3.367B
13.87%
4.02B
19.39%
4.712B
17.21%
4.245B
-9.91%
4.572B
7.70%
4.912B
7.44%
EBITDA
YoY % growth
17.64M
22.67%
70.8M
301.36%
136.212M
92.39%
168.1M
23.41%
222.84M
32.56%
277.21M
24.40%
353.48M
27.51%
429.98M
21.64%
458.04M
6.53%
533.38M
16.45%
616.1M
15.51%
EBIT
YoY % growth
-42.4M
9.98%
3.6M
108.49%
12.797M
255.47%
28.029M
119.03%
138.65M
394.67%
187.19M
35.01%
326.71M
74.53%
395.56M
21.07%
460.86M
16.51%
538.43M
16.83%
N/A
Operating Margin
-4.67%0.27%0.65%1.08%4.69%5.56%8.13%8.39%10.86%11.78%N/A
EPS
YoY % growth
0.02
109.52%
0.91
4,450.00%
0.88
-3.30%
0.75
-15.27%
1.01
34.87%
1.28
27.29%
1.79
39.66%
2.19
22.60%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.06
-75.09%
0.23
-33.33%
0.24
-20.69%
0.29
621.04%
0.30
430.78%
0.26
13.62%
0.29
23.11%
0.34
17.31%
0.32
6.27%
Revenue
Q2Q % growth
658.69M
18.46%
718.42M
12.31%
734.19M
13.45%
745.83M
20.02%
761M
15.53%
808.97M
12.60%
823.09M
12.11%
855.65M
14.72%
873.29M
14.76%
EBITDA
Q2Q % growth
28.758M
-77.05%
49.431M
199.69%
52.432M
-22.96%
58.567M
-23.55%
61.753M
114.73%
62.11M
25.65%
66.056M
25.98%
71.484M
22.06%
69.578M
12.67%
EBIT
Q2Q % growth
5.211M
173.40%
24.971M
291.95%
37.66M
333.47%
34.647M
377.89%
38.352M
635.98%
49.982M
100.16%
55.528M
47.45%
63.402M
82.99%
60.071M
56.63%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.04
-86.67%
0.34-0.30-88.41%
Q2 2024
Q2Q % growth
0.30
114.29%
0.260.0417.44%
Q1 2024
Q2Q % growth
0.34
61.90%
0.240.1039.63%
Q4 2023
Q2Q % growth
0.23
130.00%
0.150.0852.95%
Q3 2023
Q2Q % growth
0.30
-49.15%
0.070.23333.18%
Q2 2023
Q2Q % growth
0.14
40.00%
0.110.0322.82%
Q1 2023
Q2Q % growth
0.21
75.00%
0.200.012.68%
Q4 2022
Q2Q % growth
0.10
25.00%
0.17-0.07-39.73%
Q3 2022
Q2Q % growth
0.59
2,066.67%
0.120.47392.67%
Q2 2022
Q2Q % growth
0.10
600.00%
0.050.05103.85%
Q1 2022
Q2Q % growth
0.12
1,300.00%
0.000.126,040.59%
Q4 2021
Q2Q % growth
0.08
900.00%
0.010.07850.88%
Q3 2021
Q2Q % growth
-0.03 -0.030.009.61%
Q2 2021
Q2Q % growth
-0.02
33.33%
-0.040.0244.99%
Q1 2021
Q2Q % growth
-0.01
92.86%
-0.070.0684.77%
Q4 2020
Q2Q % growth
-0.01
85.71%
-0.050.0478.59%
Q3 2020
Q2Q % growth
-0.03
66.67%
-0.040.0132.49%
Q2 2020
Q2Q % growth
-0.03
88.46%
-0.100.0770.02%
Q1 2020
Q2Q % growth
-0.14
54.84%
-0.13-0.01-5.72%
Q4 2019
Q2Q % growth
-0.07 -0.04-0.03-92.52%
Q3 2019
Q2Q % growth
-0.09
-125.00%
-0.130.0428.76%
Q2 2019
Q2Q % growth
-0.26
-766.67%
-0.23-0.03-13.83%
Q1 2019
Q2Q % growth
-0.31
-1,650.00%
-0.340.037.99%
Q4 2018
Q2Q % growth
-0.07 -0.04-0.03-70.54%
Q3 2018
Q2Q % growth
-0.04 -0.050.0111.20%
Q2 2018
Q2Q % growth
-0.03 -0.040.0124.86%
Q1 2018
Q2Q % growth
0.02 -0.040.06152.00%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
621.401M
21.60%
633.42M-12.019M-1.90%
Q2 2024
Q2Q % growth
647.145M
37.94%
642.8M4.345M0.68%
Q1 2024
Q2Q % growth
639.653M
49.56%
606.83M32.823M5.41%
Q4 2023
Q2Q % growth
556.055M
45.41%
547.82M8.235M1.50%
Q3 2023
Q2Q % growth
511.015M
44.93%
514.33M-3.315M-0.64%
Q2 2023
Q2Q % growth
469.136M
46.65%
465.31M3.826M0.82%
Q1 2023
Q2Q % growth
427.69M
43.95%
438.68M-10.99M-2.51%
Q4 2022
Q2Q % growth
382.4M
53.95%
376.66M5.74M1.52%
Q3 2022
Q2Q % growth
352.6M
58.47%
360.34M-7.74M-2.15%
Q2 2022
Q2Q % growth
319.9M
44.03%
300.82M19.08M6.34%
Q1 2022
Q2Q % growth
297.1M
38.12%
289.64M7.46M2.58%
Q4 2021
Q2Q % growth
248.4M
0.77%
236.22M12.18M5.16%
Q3 2021
Q2Q % growth
222.5M
-7.14%
227.88M-5.38M-2.36%
Q2 2021
Q2Q % growth
222.1M
2.21%
219.09M3.01M1.37%
Q1 2021
Q2Q % growth
215.1M
-2.76%
214.92M180K0.08%
Q4 2020
Q2Q % growth
246.5M
218.89%
264.17M-17.67M-6.69%
Q3 2020
Q2Q % growth
239.6M
8.86%
266.41M-26.81M-10.06%
Q2 2020
Q2Q % growth
217.3M
13.18%
243.44M-26.14M-10.74%
Q1 2020
Q2Q % growth
221.2M
11.83%
241.5M-20.3M-8.41%
Q4 2019
Q2Q % growth
77.3M
-59.97%
235.19M-157.89M-67.13%
Q3 2019
Q2Q % growth
220.1M
46.83%
220.08M20K0.01%
Q2 2019
Q2Q % growth
192M
33.06%
194.53M-2.53M-1.30%
Q1 2019
Q2Q % growth
197.8M
41.59%
194.63M3.17M1.63%
Q4 2018
Q2Q % growth
193.1M 190.63M2.47M1.30%
Q3 2018
Q2Q % growth
149.9M 144.45M5.45M3.77%
Q2 2018
Q2Q % growth
144.3M 143.23M1.07M0.75%
Q1 2018
Q2Q % growth
139.7M 142.15M-2.45M-1.72%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -85.94% -45.2% -45.31%
Revenue0% -0.54% -0.54% -0.69%